About the Event
In this installment of Internal Medicine Grand Rounds, Anna Capasso, M.D., Ph.D., and Joga Ivatury, M.D., MHA, present “Recent Updates in Clinical and Surgical Management of Rectal Cancer.” Capasso is an assistant professor in the Department of Oncology and a courtesy assistant professor in the Department of Internal Medicine at Dell Medical School. Ivatury is an associate professor in the Department of Surgery and Perioperative Care at Dell Med.
Please register by 5 p.m. on Tuesday, April 4.
For more information, contact Lyndsey Loughran.
By the end of this presentation, the audience participant should be able to:
- Discuss recent changes in neoadjuvant treatment management
- Compare role of surgery versus watch and wait
- Discuss role of chemoradiation
- Primary: Department of Internal Medicine faculty
- Secondary: Department of Internal Medicine residents and health care team members
This activity has been designed to promote some of the following desired physician attributes and competencies:
- ACGME: Patient Care, Medical Knowledge, Practice-based Learning and Improvement, Professionalism, Systems-based Practice
- IOM: Provide patient-centered care, Work in interdisciplinary teams, Employ evidence-based practice, Apply quality improvement
- IECC: Interprofessional Communication, Teams and Teamwork
Anna Capasso, M.D., Ph.D., and Joga Ivatury, M.D., MHA, speakers for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.
Parker Hudson, M.D., MPH, FACP; Beth Nelson, M.D.; Kirsten Gibbs Nieto, M.D.; Snehal Patel, M.D.; Chris Moreland, M.D., MPH; Ollieta Nicholas, MBA, FACHE; and Lyndsey Loughran, MHQS, planners for this educational activity, have no relevant financial relationships with ineligible companies to disclose.
Annie Feagins, M.D., received grants/research funding from Corevitas, Takeda and Arena.
Yan Liu, M.D., Ph.D., received royalties and is a patent holder for G1 Therapeutics.
Kevin Hackshaw, M.D., is a stock shareholder of Pfizer, Merck and Exagen.
Anokhi Jambusaria-Pahlajani, M.D., MSCE, is a consultant with Regeneron Pharmaceuticals, Inc.
Brian Lee, M.D., is on the advisory board of HealthMap Solution Inc.
The CME Advisory Committee, reviewers of this educational activity, have no relevant relationships with ineligible companies to disclose.
All of the relevant financial relationships listed have been mitigated.
The University of Texas at Austin Dell Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas at Austin Dell Medical School designates this internet live course for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This course has been designated by The University of Texas at Austin Dell Medical School for 1 credit(s) of education in medical ethics and/or professional responsibility.